Scholarlink

<p>Quality of life (QoL) of Sinonasal malignancies (SNM) patients can be assessed in various manners. SNOT -22 test is a quick and widely available tool that was initially developed for chronic rhinosinusitis. The aim of the present study is to provide evidence on the validity of SNOT-22 in the assessment of QoL in SNM patients. A monoinstitutional retrospective cohort of patients with primary SNM who received endoscopic sinus surgery. Statistical correlations among many administered PROMs were calculated. A cohort of 55 patients was included and chemoradiation were administered postoperatively in 32 (58%) cases. Mean SNOT-22 was 25.7, 20.9, and 15.9 at t0, t1, and t2, respectively. Significant moderate to strong relationships among SNOT-22, ASK-9, QLQ-GLOBAL. Correlation coefficients increased over time after surgery. SNOT-22 may play a meaningful role in the assessment of QoL in patients treated for sinonasal cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Is SNOT-22 A Meaningful Tool for Assessing Quality of Life in Sinonasal Cancer patients?

  • 期刊论文

  • 发表日期：

    2025年11月1日

查看全文
  • Luca Giovanni Locatello,
  • Pietro Orlando,
  • Saverio Caini,
  • Giandomenico Maggiore

摘要

Quality of life (QoL) of Sinonasal malignancies (SNM) patients can be assessed in various manners. SNOT -22 test is a quick and widely available tool that was initially developed for chronic rhinosinusitis. The aim of the present study is to provide evidence on the validity of SNOT-22 in the assessment of QoL in SNM patients. A monoinstitutional retrospective cohort of patients with primary SNM who received endoscopic sinus surgery. Statistical correlations among many administered PROMs were calculated. A cohort of 55 patients was included and chemoradiation were administered postoperatively in 32 (58%) cases. Mean SNOT-22 was 25.7, 20.9, and 15.9 at t0, t1, and t2, respectively. Significant moderate to strong relationships among SNOT-22, ASK-9, QLQ-GLOBAL. Correlation coefficients increased over time after surgery. SNOT-22 may play a meaningful role in the assessment of QoL in patients treated for sinonasal cancer.